Nexome Capital Markets Ltd - 508905 - Trading Approval Of 1920000 Equity Shares Of Rs. 10.00 /- Each Issued At A Premium Of Rs. 54.00/- Bearing Distinctive Numbers From 8815501 To 10735500 Issued To Promoter And Non Promoter On A Preferential Basis Pursuant To Conversion Of Warrants.
Nexome Capital Markets obtained trading approval for 1.92 million equity shares, which are now listed on the exchange. These shares, valued at Rs. 64 each, were issued to promoters and non-promoters following warrant conversion.
May 21 2026 10:05:00
Nexome Capital Markets Ltd - 508905 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Nexome Capital Markets has reported the appropriate utilization of Rs. 22.04 crore raised through its Rights Issue. The Monitoring Agency report for Q4 FY26 confirms no material deviations from the stated objects in the offer document, ensuring funds were used as planned.
May 14 2026 17:05:00
Nexome Capital Markets Ltd - 508905 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.05.2026
Nexome Capital Markets board reviewed and took on record the Monitoring Agency Report on the utilization of proceeds from its Rights Issue for the quarter ended March 31, 2026. The report was previously reviewed by the Audit Committee.
May 14 2026 16:05:00
Nexome Capital Markets Ltd - 508905 - Corporate Action-Board to consider Dividend
Nexome Capital Markets board to consider a Final Dividend for FY ended March 31, 2026. The meeting is scheduled for May 25, 2026, for this recommendation.
May 13 2026 17:05:00
Nexome Capital Markets Ltd - 508905 - Board Meeting Intimation for Reviewing And Taking On Record The Monitoring Agency Report For The Quarter Ended March 31, 2026.
Nexome Capital Markets board meeting scheduled for May 14, 2026, to review the Monitoring Agency Report on the utilization of proceeds from its recent Rights Issue, ensuring compliance with SEBI regulations.
May 08 2026 17:05:00
Nexome Capital Markets Ltd - 508905 - Update on board meeting
Nexome Capital Markets board meeting, originally on May 11, has been rescheduled to May 25, 2026. The board will consider Q4 FY26 financial results and recommend a final dividend for FY26.
May 08 2026 17:05:00
Nexome Capital Markets Ltd - 508905 - Intimation Of Obtaning Listing Approval For 19,20,000 Equity Shares
Nexome Capital Markets Ltd secured BSE approval for the listing of 1.92 million equity shares. These shares were issued at Rs. 64 each to Promoter and Non-Promoters upon conversion of warrants.
May 07 2026 18:05:00
Nexome Capital Markets Ltd - 508905 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2026.
Nexome Capital Markets will hold a Board Meeting on May 11, 2026. The primary agenda is to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
May 05 2026 18:05:00
Read More